Shingles Vaccine Linked to Lower Cardiac Event Risk in Heart Disease Patients

Fresh research presented at the American College of Cardiology’s Annual Scientific Session (ACC.26) suggests a significant link between shingles vaccination and a reduced risk of serious cardiac events in individuals with heart disease. The study, set to be fully presented in New Orleans from March 28-30, found that those who received the shingles vaccine experienced nearly half the rate of major adverse cardiovascular outcomes a year later compared to their unvaccinated counterparts.

Shingles and Heart Health: An Unexpected Connection

Shingles, or herpes zoster, is a painful rash caused by the reactivation of the varicella-zoster virus – the same virus that causes chickenpox. Even as typically thought of as a dermatological issue, increasing evidence points to a more complex relationship between shingles and cardiovascular health. The inflammation associated with shingles, and potentially the virus itself, may contribute to an increased risk of stroke, heart attack, and other cardiac problems. This new research builds on that understanding, suggesting that preventing shingles through vaccination could offer a protective effect for those already vulnerable due to underlying heart conditions.

The American College of Cardiology has been actively consolidating recommendations on immunizations as part of cardiovascular care, recognizing the importance of protecting patients from respiratory illnesses like influenza, COVID-19, and RSV. Their 2025 Concise Clinical Guidance emphasizes clinician-patient discussions about vaccination during cardiology visits as a key opportunity to integrate preventative care.

What the Study Showed – and What It Didn’t

Details about the study’s methodology, including the exact sample size and specific cardiac events measured, are still forthcoming with the full presentation at ACC.26. However, the preliminary findings indicate a substantial reduction in risk among vaccinated individuals. It’s important to note that this study demonstrates an association, not necessarily causation. While the results strongly suggest a protective effect from the shingles vaccine, they don’t definitively prove that the vaccine caused the reduction in cardiac events. Other factors, such as lifestyle differences or more proactive healthcare seeking among vaccinated individuals, could potentially contribute to the observed outcome.

Further research will be needed to confirm these findings and to understand the underlying mechanisms linking shingles vaccination to improved cardiovascular outcomes. Researchers will need to account for potential confounding variables and explore whether the protective effect varies based on the type of heart disease, age, or other individual characteristics.

Current Vaccination Guidance for People with Heart Disease

The Centers for Disease Control and Prevention (CDC) currently recommends shingles vaccination for all adults aged 50 years and older, regardless of whether they’ve had chickenpox. Updated ACC guidelines reinforce the importance of several vaccines for individuals with cardiovascular disease, including influenza, COVID-19, pneumococcal pneumonia, and now, potentially, shingles.

There are two main shingles vaccines available: Shingrix and Zostavax. Shingrix is the preferred vaccine, as it is more effective and provides longer-lasting protection. Zostavax is a live vaccine and is no longer available in the United States. The CDC provides detailed information on shingles vaccination, including recommendations for specific populations and potential side effects, on their website.

Understanding Risk: Relative vs. Absolute

The study reports a near halving of the rate of cardiac events in the vaccinated group. This is a significant relative risk reduction. However, it’s crucial to understand the absolute risk reduction as well. For example, if the baseline risk of a serious cardiac event in unvaccinated individuals with heart disease is 5% per year, a 50% relative risk reduction would mean the risk drops to 2.5% per year. While substantial, this illustrates that even with vaccination, a degree of risk remains. It’s important to discuss your individual risk factors and the potential benefits of vaccination with your healthcare provider.

Beyond Shingles: The Broader Picture of Immunization and Cardiac Health

The emerging link between shingles vaccination and cardiovascular health underscores the growing recognition of the interplay between the immune system and heart disease. Inflammation plays a central role in the development and progression of many cardiovascular conditions, and vaccines that can modulate the immune response may offer unexpected benefits beyond preventing infectious diseases. The ACC’s focus on integrating immunization into cardiovascular care reflects this evolving understanding.

The ACC’s 2025 guidance also highlights the importance of influenza and pneumococcal vaccinations for individuals with heart disease. Influenza can exacerbate existing cardiac conditions and increase the risk of heart attack and stroke. Pneumococcal pneumonia can lead to serious complications, including sepsis and death, particularly in those with underlying heart problems. The ACC Expert Consensus Statement provides a comprehensive overview of vaccine-specific recommendations and strategies to improve vaccination rates.

What Comes Next: Surveillance and Guidance Updates

The findings from the ACC.26 presentation will likely prompt further investigation into the relationship between shingles vaccination and cardiovascular health. Researchers may conduct larger, more rigorous studies to confirm the observed association and to identify the underlying mechanisms. Public health agencies, such as the CDC and the Advisory Committee on Immunization Practices (ACIP), will review the new evidence and may update their vaccination recommendations accordingly. Ongoing surveillance of cardiovascular outcomes in vaccinated and unvaccinated populations will also be crucial to monitor the long-term impact of shingles vaccination on heart health. Clinicians should stay informed about the latest guidance and engage in shared decision-making with their patients regarding vaccination.